CrossBoss and Hybrid Registry on Coronary Chronic Total Occlusions

CompletedOBSERVATIONAL
Enrollment

1,177

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

January 31, 2017

Conditions
Chronic Total Occlusion of Coronary Artery
Interventions
OTHER

Data registration

Patients diagnosed with the presence of one or more chronic total occlusions (CTOs) and who will receive treatment via percutaneous coronary intervention (PCI), which is standard medical practice for these types of lesions. This study will collect data on the patients' demographics, CTO characteristics, procedure and outcome. This will be done in the form of a registry

Trial Locations (21)

1090

UZ Brussel, Brussels

3500

Hasselt University, Hasselt

3600

Ziekenhuis Oost-Limburg, Genk

5623

Catharina Ziekenhuis, Eindhoven

13700

Clinique de Marignane, Marignane

38000

Groupe Hospitalier Mutualiste (GHM), Grenoble

42270

Hôpital Nord - CHU de St Etienne, Saint-Priest-en-Jarez

44277

Nouvelles Cliniques Nantaises (NCN), Nantes

1091 AC

Onze-Lieve-Vrouwe Gasthuis (OLVG), Amsterdam

3015 CE

Erasmus MC, Rotterdam

3584 CX

Universitair Medisch Centrum Utrecht (UMCU), Utrecht

Unknown

Basildon University Hospital, Basildon

Ninewells Hospital, Dundee

Golden Jubilee Hospital, Glasgow

Kings College London, London

Freeman Hospital, Newcastle

Nottingham City Hospital, Nottingham

BT9 7AB

Belfast City Hospital, Belfast

BS1 2LY

University Hospital of Bristol, Bristol

EH16 4SA

Royal Infirmary of Edinburgh, Edinburgh

E2 9JX

London Chest Hospital, London

All Listed Sponsors
lead

Hasselt University

OTHER

NCT02075372 - CrossBoss and Hybrid Registry on Coronary Chronic Total Occlusions | Biotech Hunter | Biotech Hunter